SARS-CoV-2 has recently emerged, becoming a global threat, affecting directly all
human beings owing to its morbidity and mortality and indirectly, due to the
enormous economic and psychological impact produced by social isolation, the
most effective measure so far, but unsustainable for a long period. The
scientific effort to understand and control SARS-CoV-2 transmission and clinical
impact has been huge, and important achievements are highlighted in this review.
Diagnosis is central and is the first step in recognizing and fighting any
infectious agent. Instrumental to that is the quality of the data, relying on
serological and molecular surveys in addition to trustworthy clinical records.
However, the fast spread of a virus adapted for human-to-human respiratory
transmission raised a demand for millions of molecular tests that are simply not
available. Several candidate drugs are under evaluation in clinical trials.
Those with an already recognized safety profile are more auspicious, since, if
proven effective, can cut several steps of production and phase 2 and 3 trials.
More than one hundred vaccine prototypes are in different stages of development,
however, safety and efficacy evaluations cannot be obviated, implicating, most
optimistically, in at least months for us to have an effective immunization, the
definite measure to allow a safe return to the pre-pandemic lifestyle. Science
has never been more necessary and present in daily life. Relying on the best of
human wit is the only way out to this pandemic, saving as many lives as
possible.